Study Shows Combination of CBD and Terpenes Can Fight COVID-19, But Where Does That Leave THC?
Marijuana Stocks, Finance, & InvestingUncategorized August 15, 2020 MJ Shareholders
With the COVID-19 pandemic continuing to rage around the world, many are left wondering what, if any, is cannabis’ role in ameliorating the spread or possibly treating patients affected by the virus? Cannabis’ therapeutic benefits have been extolled for centuries, and especially in the last decade, but can it also be used to treat this increasingly rampant virus?
Last month, Israeli researchers from firms Eybna and CannaSoul Analytics conducted a study that suggested combining CBD and terpenes was three times more effective at preventing cytokine activity than corticosteroid dexamethasone. Cytokines are small secreted proteins that are released by cells and effect the interactions and communications between cells.
Cytokine storm, also known as hypercytokinemia, is a physiological reaction in which the immune system causes an excessive release of cytokines. It is one of the symptoms of COVID-19 and is known to cause inflammation, swelling, loss of organ function, pain.
Studies done by Israeli firms Eybna and CannaSoul Analytics suggest that a combination of CBD and terpenes could be effective against deadly cytokine storms caused by COVID-19.
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers